Skip to content
mapperlab
← Dashboard
Stock

AHCO

AdaptHealth Corp.
Health CareHealth Care EquipmentLatest close $116 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
9
Current + past
New this quarter
1
Exited this quarter
0

Marquee-fund ownership over time

Feb 16, 2021Aug 14, 2024May 15, 2025May 15, 2026
Now
6

This quarter's activity

New positions opened

Positions exited

None.

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Citadel Advisors re-entered$9.74$11+10%
Two Sigma Investments re-entered$9.74$11+10%
D.E. Shaw$9.74$11+10%
AQR Capital Management$9.74$11+10%
Millennium Management re-entered$9.74$11+10%
Renaissance Technologies$8.90$11+20%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Bridgewater Associates→ $8.90-65%
Maverick Capital→ $10-69%
Viking Global Investors→ $17-33%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at AdaptHealth Corp.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
2
Filings · last 90d
9
Total on file
289
Recent SEC buffer
Most recent
Jun 3, 2026

30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 289 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · AdaptHealth Corp.

Annual figures sourced directly from AdaptHealth Corp.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$3.24B
FY2025-0% YoY
Net income
-$70.79M
FY2025-178% YoY
EPS (diluted)
$-0.5200
FY2025-185% YoY
Free cash flow(?)
$219.38M
FY2025-7% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for AdaptHealth Corp. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Two Sigma InvestmentsQ2 2026open$11$11+1%
Citadel AdvisorsQ1 2026open$10$11+4%
Millennium ManagementQ2 2025open$9.04$11+19%
Renaissance TechnologiesQ2 2025open$8.90$11+20%
Citadel AdvisorsQ3 2024Q3 2025$9.74$9.49-3%
Two Sigma InvestmentsQ3 2024Q3 2025$9.74$9.49-3%
D.E. ShawQ3 2024open$9.74$11+10%
AQR Capital ManagementQ3 2024open$9.74$11+10%
Millennium ManagementQ3 2024Q1 2025$9.74$8.78-10%
Viking Global InvestorsQ3 2021Q2 2022$25$17-33%
Bridgewater AssociatesQ3 2021Q2 2025$25$8.90-65%
Maverick CapitalQ1 2021Q4 2024$32$10-69%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.